Screener
BioLife Solutions BLFS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | (5,155) | (3,388) |
| Sales taxes payable | (187) | (625) |
| Other | 26 | — |
| Net cash provided by operating activities | 5,857 | 9,095 |
| Cash flows from investing activities | ||
| Purchases of available-for-sale securities | (35,355) | (64,303) |
| Proceeds from sale of available-for-sale securities | 4,690 | 1,755 |
| Maturities of available-for-sale securities | 28,586 | 8,390 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's operating cash flow?
- BioLife Solutions (BLFS) reported operating cash flow of $6.35M in Q2 2026.
- How has BioLife Solutions's operating cash flow changed year-over-year?
- BioLife Solutions's operating cash flow decreased by 13.8% year-over-year, from $7.37M to $6.35M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about BioLife Solutions's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude